Dayi Hu is the President of the Chinese Society of Cardiology (CSC), President of the China Committee of Cardio-Cerebral-Vascular Diseases of GSC, a past president of the Chinese College of Cardiovascular Physicians (CCCP), Chief of the Intervention Centre at Peking University People’s Hospital, Dean of Clinical Research Institute at Shanghai’s Fudan University and a member of The International Academy of Sciences for Europe and Asia(IASEA). Professor Dayi Hu is a member of the Board of Directors of the International Society of Cardiovascular Pharmacotheraphy (ISCP), the editor-in-chief of Chinese Journal of Cardiology, an international board member of Journal of Clinical Cardiology, Journal of the American College of Cardiology, European Heart Journal, Nature Cardiovascular Medicine and also many other national and international medical journals. Professor Hu has been the editor-in-chief or major translator of 50 professional books, three of which have been published in United States.

Research Interest :Cardiology, Cardiovascular Pharmacology, Cardio-Cerebral-Vascular Diseases

Dr Antonia Anna Lukito is Interventional consultant cardiologist at Siloam Karawaci Hospital and currently Head of Cardiovascular Department in Pelita Harapan University, and also an Independent Consultant of MRIN Ethics Committee. Dr Antonia joining several overseas formal courses such as Advanced Cardiology Course at Victoria Heart Center Melbourne in 1996, Cardiovascular CT Training at Cologne Germany in 2005, Carotid Intervention Training at NTUH Taipei 2012, Optical Coherence Tomography(OCT) Training at Finlandia 2012, and Rotablator & IVUS hands-on training at Japan in 2013. She also actively involved in Indonesian Heart Association (PERKI) as vice chairman of Indonesian Heart Consumer Cooperatives (KKJI), chairman of Woman Cardiology working roup, and as scientific & education committee in IHA Banten chapter. Dr Antonia also active in Indonesian Society of Hypertension (InaSH), Indonesian Heart Rhythm Society (InaHRS), and Indonesian Society of Interventional Cardiology (ISIC).

Research Interest:Interventional Cardiology ,Hypertension, Cardiovascular Research

Dr. Robaayah Zambahari is known for her extensive experience in cardiology, both locally and internationally. Dr Robaayah is CEO and managing director of the National Heart Institute (IJN) in 2009. She pursued medicine at University of Malaya in 1977 and received speciality training at the Academy of Medicine of Malaysia. She was appointed senior consultant cardiologist and head of department at IJN in 1992. She is a member of Royal College of Physicians of Glasgow, the Royal College of Physicians of London, and the American College of Cardiology, Emeritus member of the Asia Pacific Society of Interventional Cardiology , FAPSIC, October 2006, Member of the National Heart Association of Malaysia, Member of the ASEAN Federation of Cardiology.

Research Interest:Clinical research in cardiology,Interventional Cardiology,Development of Evidence-based Clinical Practice Guidelines

Fekry El Deeb is one of the first interventional Cardiologists in the Middle East. He started practicing Coronary Angioplasty at the Catharina Hospital, The Netherlands in 1986. He has worked in major hospitals such as the King Faisal Specialist Hospital and Research Center and the King Fahad National Guard hospital, Riyadh, Saudi Arabia as a Consultant and Director of the Cardiac Catheterization Laboratory. With interventional experience of more than 25 years, Dr. Fekry has performed over 10,000 different coronary, peripheral and valvular procedures.

Research Interest:Complex Coronary Angioplasty and Stenting, Carotid Angioplasty and Stenting, Percutaneous Valvuloplasty & All peripheral Angioplasty and Stenting

Dr Avanzas graduated in Medicine at Universidad de Navarra, Pamplona, Spain. He completed Senior House Officer posts and registrar training in Cardiology at Gregorio Marañón Hospital in Madrid, Spain. He took up a Spanish Heart Foundation Research Fellowship at Coronary Artery Research Unit, St. George´s Hospital Medical School in London and in 2002 he was appointed as Associate Research Investigator of the Cardiovascular Biology Research Centre at St. George´s Hospital in London. He was appointed as Consultant Cardiologist in Gregorio Marañón Hospital, Madrid, Spain and he also took up an Interventional Cardiology Fellowship in Hospital Universitario Central de Asturias, Oviedo, Spain. He is now senior Consultant in Invasive Cardiology in this Hospital. Dr Avanzas is author of more than 150 peer-reviewed indexed articles and invited contributions. He is also involved in teaching medical students. He is a frequent speaker at national and international meetings.

Research Interest: cardiac syndrome X and interventional cardiology, particularly percutaneous valve replacement

Dr. Heinz-Peter Schultheiss, Professor of Internal Medicine and Cardiology, is CEO of Institute for cardiac diagnostic and therapy (IKDT) Berlin, Germany since 2003. He was the chairman of the Working group “Inflammatory heart muscle diseases“ of the German Society of Cardiology, Chairman of the “Working Group on Myocardial and Pericardial Disease“ of the European Society of Cardiology, Member of the "Council on Cardiomyopathies“ of the International Society of Cardiology, Chairman of the Medical Society Berlin, Member of German Society for Internal Medicine, Member of European Society of Cardiology.

Research Interest: Cardiomyopathy,Cardiac diseases, Inflammatory Heart diseases

Dr. Po is an exceptional teacher and researcher. In addition to teaching and research, Dr. Po mentors electrophysiology research fellows and is an international lecturer. He has been awarded research grants from the National Institutes of Health, American Heart Association and other industrial sponsors. Dr. Po received the Provost's Research Award for Junior Faculty in 2006 from the University of Oklahoma Health Sciences Center.

Research Interest:Determinants of catheter ablation failure, Arrhythmogenesis of pulmonary veins,Arrhythmia/heart rhythm disorders,Neural basis of cardiac arrhythmia

Samer Ellahham, MD, CPHQ, EFQM, FACMQ, FACP, FACC, FAHA, FCCP Cardiovascular Consultant Cleveland Clinic Abu Dhabi Dr. Ellahham has served as Chief Quality Officer for SKMC since 2009. In his role, Dr. Ellahham has led the development of a quality and safety program that has been highly successful and visible and has been recognized internationally by a number of awards. He is currently Cleveland Clinic Caregiver and cardiology consultant in Cleveland Clinic Abu Dhabi, in Abu Dhabi, UAE. He is the Eminent Editor of The Journal of Cardiology & Cardiovascular Therapy. In addition, he serves on the editorial board of American Journal of Medical Quality, Developments in Clinical & Medical Pathology (DCMP), the Joint Commission Journal on Quality and Patient Safety, Telehealth and Medicine Today (TMT), Blockchain journal (BHTY), Medical Science, Open Journal of Cardiatic Research, UPI Journal of Pharmaceutical, Medical and Health Sciences (UPI-JPMHS, Open Access Research in Anatomy, Gerontology & Geriatrics studies and Open Access Journal of Clinical Trials, Hypertension Today Journal and Focus on Hypertension Journal.

Research Interest: Heart Failure and Transplant, Adult Congenital and Pediatric Cardiology, Cardio-oncology and Peripheral Vascular Disease Sections, Heart failure, ischemic heart disease, and valvular heart disease